Guangdong HEC Pharma files HKEX next-day disclosure return on share repurchase

• Guangdong HEC Pharmaceutical filed a next-day disclosure return showing a repurchase of 41,200 H shares on July 28, 2026.
• Buyback price range HKD 33.68 to HKD 34.5; aggregate consideration HKD 1.41 million.
• Total repurchased/cancelled shares: 41,200 repurchased; 0 cancelled.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong HEC Pharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260728-12259065), on July 28, 2026, and is solely responsible for the information contained therein.